- BusinessMen's Health
And you don't lose your side-view mirrors when you take the Ford's doors off, another big benefit over the Jeep Wrangler.
CNN, MSNBC Cut Away From Donald Trump’s Rose Garden Remarks As He Launches Into Campaign Attack On Joe Biden
CNN and MSNBC cut away from President Donald Trump's Rose Garden remarks on Tuesday after he veered from an announcement about the situation in Hong Kong to a lengthy campaign attack on Joe Biden and his economic and energy proposals. CNN's Wolf Blitzer explained that they network cut away because it was "deteriorating into a […]
- LifestyleBusiness Insider
CDC director predicts this fall and winter will be 'one of the most difficult times we've experienced in American public health'
Colder temperatures could minimally boost coronavirus transmission, but the greater threat is hospital overcrowding during flu season.
- U.S.CBS News
The brutal heat wave baking the Southwest and lower Plains states is going to move east and north to engulf much of the nation this week.
Moderna Inc (NASDAQ: MRNA) shares are surging above the $70 level for the first time since late May following sell-side commentary on its coronavirus vaccine program.The Moderna Analyst: Jefferies analyst Michael Yee initiated coverage of Moderna with a Buy rating and $90 price target.The Moderna Thesis: There is good probability the vaccine will work and get at least emergency approval by early 2021, Yee said in a note, citing his discussions with key opinion leaders and disclosures made by the company thus far.Given the likelihood of demand to remain elevated in the first two years, the analyst estimates billions in sales. This is despite the sell-side remaining divided over whether Moderna will be successful in its pursuit for a coronavirus vaccine, he added.Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.Key catalysts for the stock are the Phase 2 readout due in fall and potential interim Phase 3 readout by the end of the year, Yee said.Jefferies' $90 per share price target gives Moderna a valuation of $35 billion. This is based $15 billion valuation for the stock, based on three-to-four times sales, and $15 billion to $20 billion platform value, which is supported by a pipeline consisting of 15 other candidates in the clinic, including 5-10 vaccines and 5-19 other therapeutic programs."$35B on MRNA if it does have a novel mRNA platform that generated a COVID vaccine in less than a year would be worthy of praise, in our view," Yee wrote in the note.As such, the firm believes the vaccine will get approved and could do over $5 billion in orders over the next few years and the stock will head higher.MRNA Price Action: Moderna shares were soaring 16.8% to $73.14 at the time of publication.Latest Ratings for MRNA DateFirmActionFromTo Jul 2020Brookline CapitalInitiates Coverage OnBuy Jul 2020JefferiesInitiates Coverage OnBuy Jun 2020BarclaysInitiates Coverage OnOverweight View More Analyst Ratings for MRNA View the Latest Analyst Ratings See more from Benzinga * Moderna Strikes Another Coronavirus Vaccine Manufacturing Deal To Ensure Overseas Supply * Revisiting Coronavirus Vaccine Timelines: Moderna Denies Delay, Pfizer Advances Project Lightspeed And More * Moderna, Catalent Collaborate On Coronavirus Vaccine Manufacturing Capacity(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
John Legend, loving wife of our internet mom Chrissy Teigen, is getting honest about his past. And as much as it pains us to hear the good name of 2019's Sexiest Man Alive besmirched, it takes a big person to face their mistakes, own up to what they did wrong, and prove with their actions […]
- EntertainmentThe Wrap
Not everyone will see the “30 Rock” reunion that will air Thursday on NBC. Multiple station groups are preempting the hour-long special, which will double as an advertisement for NBCUniversal’s 2020-21 programming and its new streaming service, Peacock.The full list of stations that are choosing to preempt the special come from station groups Gray Television, Hearst, Nexstar, Tegna and Sinclair Broadcast Group, an individual with knowledge of the situation told TheWrap. While it’s not clear exactly how many of the stations are skipping the special, those collectively represent about half of NBC’s footprint.NBC declined to comment on the reason for the preemptions, but Vulture reported that it’s over concerns the special is too focused on the new streaming service, which rolls out nationwide on Wednesday. The special is being produced by NBCUniversal’s marketing department.Also Read: '30 Rock' Reunion: Liz Lemon Shames Maskless New Yorker in First Teaser for NBC Special (Video)On Thursday, the cast of “30 Rock” will tout NBCUniversal’s 2020-21 programming in an hour-long, commercial-free event. The show will then be rebroadcast on Friday across USA Network, Bravo, E!, Oxygen, SYFY, and CNBC as well as available to stream on Peacock.Representatives from the station groups did not immediately respond to TheWrap’s request for comment.The “30 Rock” special will still air in many top markets that have stations owned and operated by NBC, including New York, Los Angeles, Chicago, Boston and Dallas. Affiliates are not required to air the programming of the broadcast network with which they are tied.Read original story Multiple NBC Affiliates Won’t Air Thursday’s ’30 Rock’ Special Due to All the Peacock Promos At TheWrap